IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Merrimack Pharmaceuticals in

CUSIP: 590328AA8 | 43 institutional holders

Quarters

Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

Wells Fargo & Company25,000
0.0% of portfolio›$23
UBS Group AG1,000
0.0% of portfolio›$1
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Wells Fargo & Company
25,000$230.0%CoreLowSan Francisco, CA2020-08-13
UBS Group AG
1,000$10.0%CoreMediumZurich, Switzerland2020-07-31
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2020-08-13